Vyvanse Capsules (lisdexamfetamine dimesylate) Briefing Materials
For the April 12, 2016 meeting of the FDA's Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.
Briefing Materials
- VYVANSE CAPSULES Labeling, 12/2015
- VYVANSE CAPSULES Safety and Drug Utilization Review
- Presentation: Pediatric Focused Safety Review: Vyvanse (lisdexamfetamine dimesylate )
- VYVANSE Sept 11, 2012 PAC Safety and Drug Utilization Review
- VYVANSE CAPSULES Clinical Review
- VYVANSE CAPSULES Statistical Review
Resources For You
- Products and Briefing Materials for the April 12, 2016 Meeting of the Pediatric Advisory Committee
- 2016 Meeting Materials, Pediatric Advisory Committee